Ming Yan, Chief Technology Officer at Cytek Biosciences, Inc. (CTKB), sold 20,000 shares at $8.76 ($175K) on 2023-07-19, disclosed to the SEC on 2023-07-20.
Scheduled sale ($175k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CTKB | SELL | 2024-03-19 | $270K | — | Filing → |
| CTKB | SELL | 2023-12-21 | $189K | — | Filing → |
| CTKB | SELL | 2023-11-21 | $121K | — | Filing → |